抗体阴性的自身免疫性脑炎的研究进展
Research Progress of Autoantibody-Negative Autoimmune Encephalitis
DOI: 10.12677/acm.2025.154968, PDF,   
作者: 戚嘉立:绍兴文理学院医学院,浙江 绍兴;王黎萍*:绍兴市人民医院神经内科,浙江 绍兴
关键词: 自身免疫性脑炎诊断标准抗体阴性误诊Autoimmune Encephalitis Diagnostic Criteria Antibody Negative Misdiagnosis
摘要: 随着自身免疫性脑炎(AE)相关抗体不断发现和诊断的完善下,AE发病率和患病率呈现逐年提高趋势,抗体阴性的自身免疫性脑炎(AbNAE)发病率和患病率也出现逐年提高的趋势。但在缺乏抗体这一重要诊断依据的情况下,如何早期诊断AbNAE,早期进行免疫治疗,改善AbNAE患者预后是现在亟待解决的问题。本文通过结合现有研究,从AbNAE的诊断、临床表现、辅助检查和治疗方案等方面综述。由于缺少相关抗体,AbNAE的诊断主要依赖于临床表现和辅助检查,MRI和动脉自选标记等技术对AbNAE有着重要诊断价值。AbNAE的治疗方案与抗体阳性AE一致,但AbNAE的预后较抗体阳性AE差。如何进一步完善诊断标准、发现特异性抗体、提高辅助检查手段、降低AbNAE误诊率和改善AbNAE患者预后是今后相关研究的主要方向。
Abstract: With the continuous discovery and improvement of autoimmune encephalitis (AE) related antibodies, the incidence and prevalence of AE have shown an increasing trend year by year, and the incidence and prevalence of antibody-negative autoimmune encephalitis (AbNAE) have also shown an increasing trend year by year. However, in the absence of antibodies, an important diagnostic basis, how to diagnose AbNAE early, conduct early immunotherapy, and improve the prognosis of AbNAE patients is now an urgent problem to be solved. This article reviews the diagnosis, clinical manifestations, auxiliary examinations and treatment plans of AbNAE by combining existing research. Due to the lack of relevant antibodies, the diagnosis of AbNAE mainly depends on clinical manifestations and auxiliary examinations. MRI and arterial self-selected markers have important diagnostic value for AbNAE. The treatment plan of AbNAE is consistent with that of antibody-positive AE, but the prognosis of AbNAE is worse than that of antibody-positive AE. How to further improve the diagnostic criteria, discover specific antibodies, improve auxiliary examination methods, reduce the misdiagnosis rate of AbNAE and improve the prognosis of AbNAE patients is the main direction of future related research.
文章引用:戚嘉立, 王黎萍. 抗体阴性的自身免疫性脑炎的研究进展[J]. 临床医学进展, 2025, 15(4): 563-570. https://doi.org/10.12677/acm.2025.154968

参考文献

[1] Li, X., Yuan, J., Liu, L. and Hu, W. (2019) Antibody-LGI 1 Autoimmune Encephalitis Manifesting as Rapidly Progressive Dementia and Hyponatremia: A Case Report and Literature Review. BMC Neurology, 19, Article No. 19. [Google Scholar] [CrossRef] [PubMed]
[2] Muñoz-Lopetegi, A., Graus, F., Dalmau, J. and Santamaria, J. (2020) Sleep Disorders in Autoimmune Encephalitis. The Lancet Neurology, 19, 1010-1022. [Google Scholar] [CrossRef] [PubMed]
[3] Dubey, D., Pittock, S.J., Kelly, C.R., McKeon, A., Lopez‐Chiriboga, A.S., Lennon, V.A., et al. (2018) Autoimmune Encephalitis Epidemiology and a Comparison to Infectious Encephalitis. Annals of Neurology, 83, 166-177. [Google Scholar] [CrossRef] [PubMed]
[4] Granerod, J., Ambrose, H.E., Davies, N.W., Clewley, J.P., Walsh, A.L., Morgan, D., et al. (2010) Causes of Encephalitis and Differences in Their Clinical Presentations in England: A Multicentre, Population-Based Prospective Study. The Lancet Infectious Diseases, 10, 835-844. [Google Scholar] [CrossRef] [PubMed]
[5] Ren, H., Fan, S., Zhao, Y. and Guan, H. (2021) The Changing Spectrum of Antibody-Mediated Encephalitis in China. Journal of Neuroimmunology, 361, Article ID: 577753. [Google Scholar] [CrossRef] [PubMed]
[6] Lancaster, E. and Dalmau, J. (2012) Neuronal Autoantigens—Pathogenesis, Associated Disorders and Antibody Testing. Nature Reviews Neurology, 8, 380-390. [Google Scholar] [CrossRef] [PubMed]
[7] Lee, W., Lee, H., Kim, D., Lee, H., Moon, J., Park, K., et al. (2022) Seronegative Autoimmune Encephalitis: Clinical Characteristics and Factors Associated with Outcomes. Brain, 145, 3509-3521. [Google Scholar] [CrossRef] [PubMed]
[8] Graus, F., Titulaer, M.J., Balu, R., Benseler, S., Bien, C.G., Cellucci, T., et al. (2016) A Clinical Approach to Diagnosis of Autoimmune Encephalitis. The Lancet Neurology, 15, 391-404. [Google Scholar] [CrossRef] [PubMed]
[9] Flanagan, E.P., Geschwind, M.D., Lopez-Chiriboga, A.S., Blackburn, K.M., Turaga, S., Binks, S., et al. (2023) Autoimmune Encephalitis Misdiagnosis in Adults. JAMA Neurology, 80, 30-39. [Google Scholar] [CrossRef] [PubMed]
[10] Galardi, M.M., Sowa, G.M., Crockett, C.D., Rudock, R., Smith, A.E., Shwe, E.E., et al. (2022) Pathogen and Antibody Identification in Children with Encephalitis in Myanmar. Annals of Neurology, 93, 615-628. [Google Scholar] [CrossRef] [PubMed]
[11] Venkatesan, A., Michael, B.D., Probasco, J.C., Geocadin, R.G. and Solomon, T. (2019) Acute Encephalitis in Immuno-competent Adults. The Lancet, 393, 702-716. [Google Scholar] [CrossRef] [PubMed]
[12] Hollowell, J.G., Staehling, N.W., Flanders, W.D., Hannon, W.H., Gunter, E.W., Spencer, C.A., et al. (2002) Serum TSH, T4, and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). The Journal of Clinical Endocrinology & Metabolism, 87, 489-499. [Google Scholar] [CrossRef] [PubMed]
[13] Valencia-Sanchez, C., Pittock, S.J., Mead-Harvey, C., Dubey, D., Flanagan, E.P., Lopez-Chiriboga, S., et al. (2021) Brain Dysfunction and Thyroid Antibodies: Autoimmune Diagnosis and Misdiagnosis. Brain Communications, 3, fcaa233. [Google Scholar] [CrossRef] [PubMed]
[14] Vogrig, A., Joubert, B., Ducray, F., Thomas, L., Izquierdo, C., Decaestecker, K., et al. (2018) Glioblastoma as Differential Diagnosis of Autoimmune Encephalitis. Journal of Neurology, 265, 669-677. [Google Scholar] [CrossRef] [PubMed]
[15] Thomas, C., Lehrich, C., Gross, C.C., Wiendl, H., Meuth, S.G. and Melzer, N. (2018) Primary B Cell Lymphoma of the CNS Mimicking Anti-LGI1 Limbic Encephalitis. Frontiers in Neurology, 9, Article 658. [Google Scholar] [CrossRef] [PubMed]
[16] Cianfoni, A., Caulo, M., Cerase, A., Della Marca, G., Falcone, C., Di Lella, G.M., et al. (2013) Seizure-Induced Brain Lesions: A Wide Spectrum of Variably Reversible MRI Abnormalities. European Journal of Radiology, 82, 1964-1972. [Google Scholar] [CrossRef] [PubMed]
[17] Graus, F., Escudero, D., Oleaga, L., Bruna, J., Villarejo-Galende, A., Ballabriga, J., Barceló, M.I., Gilo, F., Popkirov, S., Stourac, P. and Dalmau, J. (2018) Syndrome and Outcome of Antibody-Negative Limbic Encephalitis. European Journal of Neurology, 25, 1011-1016.
[18] Griffith, S.P., Wesselingh, R., D’Aprano, F., Seery, N., Rushen, T., Kyndt, C., et al. (2024) Language Impairments in Seropositive and Seronegative Autoimmune Encephalitis. Neurological Sciences, 45, 3389-3398. [Google Scholar] [CrossRef] [PubMed]
[19] Flammer, J., Neziraj, T., Rüegg, S. and Pröbstel, A. (2023) Immune Mechanisms in Epileptogenesis: Update on Diagnosis and Treatment of Autoimmune Epilepsy Syndromes. Drugs, 83, 135-158. [Google Scholar] [CrossRef] [PubMed]
[20] Yamada, N., Inoue, T., Kuki, I., Yamamoto, N., Fukuoka, M., Nukui, M., et al. (2024) Higher Incidence of Acute Symptomatic Seizures in Probable Antibody-Negative Pediatric Autoimmune Encephalitis than in Major Antibody-Positive Autoimmune Encephalitis. Frontiers in Neurology, 15, Article 1418083. [Google Scholar] [CrossRef] [PubMed]
[21] Mojžišová, H., Krýsl, D., Hanzalová, J., Dargvainiene, J., Wandinger, K., Leypoldt, F., et al. (2023) Antibody-Negative Autoimmune Encephalitis. Neurology Neuroimmunology & Neuroinflammation, 10, e200170. [Google Scholar] [CrossRef] [PubMed]
[22] Morbelli, S., Djekidel, M., Hesse, S., Pagani, M. and Barthel, H. (2016) Role of 18F-FDG-PET Imaging in the Diagnosis of Autoimmune Encephalitis. The Lancet Neurology, 15, 1009-1010. [Google Scholar] [CrossRef] [PubMed]
[23] Dinoto, A., Cheli, M., Ajčević, M., Dore, F., Crisafulli, C., Ukmar, M., et al. (2021) ASL MRI and 18F-FDG-PET in Autoimmune Limbic Encephalitis: Clues from Two Paradigmatic Cases. Neurological Sciences, 42, 3423-3425. [Google Scholar] [CrossRef] [PubMed]
[24] Rebella, G., Cerne, D., Benedetti, L., Morbelli, S., Resaz, M., Uccelli, A., et al. (2024) FDG-PET and ASL MRI Identify Largely Overlapping Hypermetabolic and Hyperperfusion Changes in Limbic Autoimmune Encephalitis. The Quarterly Journal of Nuclear Medicine and Molecular Imaging, 68, 194-199. [Google Scholar] [CrossRef] [PubMed]
[25] Deng, B., Yu, H., Liu, X., Yu, X., Zhang, X., Li, X., et al. (2019) Reduced Dosage Rituximab in the Treatment of Anti-N-Methyl-D-Aspartate Receptor Encephalitis: An Observation Study in Chinese Patients. Journal of Neuroimmunology, 330, 81-86. [Google Scholar] [CrossRef] [PubMed]
[26] Lee, W., Lee, S., Byun, J., Sunwoo, J., Kim, T., Lim, J., et al. (2016) Rituximab Treatment for Autoimmune Limbic Encephalitis in an Institutional Cohort. Neurology, 86, 1683-1691. [Google Scholar] [CrossRef] [PubMed]
[27] Nosadini, M., Mohammad, S.S., Ramanathan, S., Brilot, F. and Dale, R.C. (2015) Immune Therapy in Autoimmune Encephalitis: A Systematic Review. Expert Review of Neurotherapeutics, 15, 1391-1419. [Google Scholar] [CrossRef] [PubMed]
[28] Rodriguez, A., Klein, C.J., Sechi, E., Alden, E., Basso, M.R., Pudumjee, S., et al. (2021) LGI1 Antibody Encephalitis: Acute Treatment Comparisons and Outcome. Journal of Neurology, Neurosurgery & Psychiatry, 93, 309-315. [Google Scholar] [CrossRef] [PubMed]
[29] Nosadini, M., Eyre, M., Molteni, E., Thomas, T., Irani, S.R., Dalmau, J., et al. (2021) Use and Safety of Immunotherapeutic Management of n-Methyl-d-Aspartate Receptor Antibody Encephalitis. JAMA Neurology, 78, 1333-1344. [Google Scholar] [CrossRef] [PubMed]
[30] Titulaer, M.J., McCracken, L., Gabilondo, I., Armangué, T., Glaser, C., Iizuka, T., et al. (2013) Treatment and Prognostic Factors for Long-Term Outcome in Patients with Anti-NMDA Receptor Encephalitis: An Observational Cohort Study. The Lancet Neurology, 12, 157-165. [Google Scholar] [CrossRef] [PubMed]
[31] Gastaldi, M., Mariotto, S., Giannoccaro, M.P., Iorio, R., Zoccarato, M., Nosadini, M., et al. (2020) Subgroup Comparison According to Clinical Phenotype and Serostatus in Autoimmune Encephalitis: A Multicenter Retrospective Study. European Journal of Neurology, 27, 633-643. [Google Scholar] [CrossRef] [PubMed]
[32] Yang, J.H., Liu, E.N., Nguyen, L., Dunn-Pirio, A. and Graves, J.S. (2023) Survival Analysis of Immunotherapy Effects on Relapse Rate in Pediatric and Adult Autoimmune Encephalitis. Neurology, 101, e2300-e2313.